Trial Profile
Phase II clinical trial of AGN 209323 [EHT/AGN 0001] for the treatment of neuropathic pain.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 19 Sep 2011
Price :
$35
*
At a glance
- Drugs AGN 209323 (Primary)
- Indications Neuropathic pain
- Focus Adverse reactions; Therapeutic Use
- 19 Sep 2011 New trial record